...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: How & who comes up with valuations?
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I believe the biotechs others presented on this board had successful Phase 11/111 clinical trials. 

I'm not sure which drugs you are referring to that have been bought out early without any proof of some success.

 

Koo

 

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply